3-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(2,3,4,5-tetrahydro-1,4-benzoxazepin-9-yl)butan-1-one;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide

C87H96FN15O8 — CID 159590204

IUPAC3-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(2,3,4,5-tetrahydro-1,4-benzoxazepin-9-yl)butan-1-one;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide
SMILESCc1cc(F)cn2c(C(C)(C)NC(=O)c3cccc4c3OCCNC4)ncc12.Cc1cccn2c(C(C)(C)CC(=O)c3cccc4c3OCCNC4)nc(C)c12.Cc1cccn2c(C3(NC(=O)c4cccc5c4OCCNC5)CC3)ncc12.Cc1cccn2c(C3(NC(=O)c4cccc5c4OCCNC5)CCC3)ncc12
InChIInChI=1S/C23H27N3O2.C22H24N4O2.C21H23FN4O2.C21H22N4O2/c1-15-7-6-11-26-20(15)16(2)25-22(26)23(3,4)13-19(27)18-9-5-8-17-14-24-10-12-28-21(17)18;1-15-5-3-11-26-18(15)14-24-21(26)22(8-4-9-22)25-20(27)17-7-2-6-16-13-23-10-12-28-19(16)17;1-13-9-15(22)12-26-17(13)11-24-20(26)21(2,3)25-19(27)16-6-4-5-14-10-23-7-8-28-18(14)16;1-14-4-3-10-25-17(14)13-23-20(25)21(7-8-21)24-19(26)16-6-2-5-15-12-22-9-11-27-18(15)16/h5-9,11,24H,10,12-14H2,1-4H3;2-3,5-7,11,14,23H,4,8-10,12-13H2,1H3,(H,25,27);4-6,9,11-12,23H,7-8,10H2,1-3H3,(H,25,27);2-6,10,13,22H,7-9,11-12H2,1H3,(H,24,26)
InChIKeyMKDGCERLEYBSLW-UHFFFAOYSA-N
MW1498.82 g/mol
LogP12.39
Rot. Bonds13

About 3-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(2,3,4,5-tetrahydro-1,4-benzoxazepin-9-yl)butan-1-one;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide

3-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(2,3,4,5-tetrahydro-1,4-benzoxazepin-9-yl)butan-1-one;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide (PubChem CID 159590204) has the molecular formula C87H96FN15O8 and a molecular weight of 1498.82 g/mol. Its IUPAC name is 3-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(2,3,4,5-tetrahydro-1,4-benzoxazepin-9-yl)butan-1-one;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide.

Molecular Properties

Compound Name3-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(2,3,4,5-tetrahydro-1,4-benzoxazepin-9-yl)butan-1-one;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide
PubChem CID159590204
Molecular FormulaC87H96FN15O8
Molecular Weight1498.82 g/mol
Exact Mass1497.76
IUPAC Name3-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(2,3,4,5-tetrahydro-1,4-benzoxazepin-9-yl)butan-1-one;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide
SMILESCc1cc(F)cn2c(C(C)(C)NC(=O)c3cccc4c3OCCNC4)ncc12.Cc1cccn2c(C(C)(C)CC(=O)c3cccc4c3OCCNC4)nc(C)c12.Cc1cccn2c(C3(NC(=O)c4cccc5c4OCCNC5)CC3)ncc12.Cc1cccn2c(C3(NC(=O)c4cccc5c4OCCNC5)CCC3)ncc12
InChIInChI=1S/C23H27N3O2.C22H24N4O2.C21H23FN4O2.C21H22N4O2/c1-15-7-6-11-26-20(15)16(2)25-22(26)23(3,4)13-19(27)18-9-5-8-17-14-24-10-12-28-21(17)18;1-15-5-3-11-26-18(15)14-24-21(26)22(8-4-9-22)25-20(27)17-7-2-6-16-13-23-10-12-28-19(16)17;1-13-9-15(22)12-26-17(13)11-24-20(26)21(2,3)25-19(27)16-6-4-5-14-10-23-7-8-28-18(14)16;1-14-4-3-10-25-17(14)13-23-20(25)21(7-8-21)24-19(26)16-6-2-5-15-12-22-9-11-27-18(15)16/h5-9,11,24H,10,12-14H2,1-4H3;2-3,5-7,11,14,23H,4,8-10,12-13H2,1H3,(H,25,27);4-6,9,11-12,23H,7-8,10H2,1-3H3,(H,25,27);2-6,10,13,22H,7-9,11-12H2,1H3,(H,24,26)
InChIKeyMKDGCERLEYBSLW-UHFFFAOYSA-N
XLogP12.39
TPSA258.61 Ų
H-Bond Donors7
H-Bond Acceptors20
Rotatable Bonds13
Heavy Atoms111
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001498.82
LogP ≤ 512.39
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1020

Analyze 3-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(2,3,4,5-tetrahydro-1,4-benzoxazepin-9-yl)butan-1-one;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(2,3,4,5-tetrahydro-1,4-benzoxazepin-9-yl)butan-1-one;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide?
The IUPAC name of 3-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(2,3,4,5-tetrahydro-1,4-benzoxazepin-9-yl)butan-1-one;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide (CID 159590204) is 3-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(2,3,4,5-tetrahydro-1,4-benzoxazepin-9-yl)butan-1-one;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide.
What is the SMILES notation for 3-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(2,3,4,5-tetrahydro-1,4-benzoxazepin-9-yl)butan-1-one;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide?
The canonical SMILES for 3-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(2,3,4,5-tetrahydro-1,4-benzoxazepin-9-yl)butan-1-one;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide is Cc1cc(F)cn2c(C(C)(C)NC(=O)c3cccc4c3OCCNC4)ncc12.Cc1cccn2c(C(C)(C)CC(=O)c3cccc4c3OCCNC4)nc(C)c12.Cc1cccn2c(C3(NC(=O)c4cccc5c4OCCNC5)CC3)ncc12.Cc1cccn2c(C3(NC(=O)c4cccc5c4OCCNC5)CCC3)ncc12.
What is the InChIKey of 3-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(2,3,4,5-tetrahydro-1,4-benzoxazepin-9-yl)butan-1-one;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide?
The InChIKey is MKDGCERLEYBSLW-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H27N3O2.C22H24N4O2.C21H23FN4O2.C21H22N4O2/c1-15-7-6-11-26-20(15)16(2)25-22(26)23(3,4)13-19(27)18-9-5-8-17-14-24-10-12-28-21(17)18;1-15-5-3-11-26-18(15)14-24-21(26)22(8-4-9-22)25-20(27)17-7-2-6-16-13-23-10-12-28-19(16)17;1-13-9-15(22)12-26-17(13)11-24-20(26)21(2,3)25-19(27)16-6-4-5-14-10-23-7-8-28-18(14)16;1-14-4-3-10-25-17(14)13-23-20(25)21(7-8-21)24-19(26)16-6-2-5-15-12-22-9-11-27-18(15)16/h5-9,11,24H,10,12-14H2,1-4H3;2-3,5-7,11,14,23H,4,8-10,12-13H2,1H3,(H,25,27);4-6,9,11-12,23H,7-8,10H2,1-3H3,(H,25,27);2-6,10,13,22H,7-9,11-12H2,1H3,(H,24,26).
What are the key properties of 3-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(2,3,4,5-tetrahydro-1,4-benzoxazepin-9-yl)butan-1-one;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide?
3-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(2,3,4,5-tetrahydro-1,4-benzoxazepin-9-yl)butan-1-one;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide has a molecular weight of 1498.82 g/mol, XLogP of 12.39, 13 rotatable bonds, 7 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(1,8-dimethylimidazo[1,5-a]pyridin-3-yl)-3-methyl-1-(2,3,4,5-tetrahydro-1,4-benzoxazepin-9-yl)butan-1-one;N-[2-(6-fluoro-8-methylimidazo[1,5-a]pyridin-3-yl)propan-2-yl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclobutyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide;N-[1-(8-methylimidazo[1,5-a]pyridin-3-yl)cyclopropyl]-2,3,4,5-tetrahydro-1,4-benzoxazepine-9-carboxamide is sourced from PubChem (CID 159590204), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).